ESSA Pharma Inc. (EPIX)
NASDAQ: EPIX · Real-Time Price · USD
1.890
+0.010 (0.53%)
Aug 1, 2025, 4:00 PM - Market closed
bluebird bio Employees
ESSA Pharma had 35 employees as of September 30, 2024. The number of employees decreased by 15 or -30.00% compared to the previous year.
Employees
35
Change (1Y)
-15
Growth (1Y)
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$814,162
Market Cap
83.36M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 35 | -15 | -30.00% |
| Sep 30, 2023 | 50 | 0 | - |
| Sep 30, 2022 | 50 | 25 | 100.00% |
| Sep 30, 2020 | 25 | 10 | 66.67% |
| Sep 30, 2018 | 15 | -10 | -40.00% |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
EPIX News
- 11 days ago - ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Approval of an Interim Order and Cash Distribution to Shareholders - PRNewsWire
- 20 days ago - ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction - PRNewsWire
- 3 months ago - ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - PRNewsWire
- 4 months ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 25, 2025 in ESSA Pharma Inc. Lawsuit - EPIX - PRNewsWire
- 5 months ago - INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ESSA Pharma - GlobeNewsWire
- 5 months ago - ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - PRNewsWire
- 5 months ago - Shareholders of ESSA Pharma Inc. Should Contact The Gross Law Firm Before March 25, 2025 to Discuss Your Rights - EPIX - PRNewsWire
- 6 months ago - ESSA Pharma Reports Financial Results for Fiscal First Quarter Ended December 31, 2024 - PRNewsWire